The COVID-19 pandemic has made it extremely difficult for ovarian cancer patients to seek proper treatment and care for their disease. Patients have been diagnosed later due to it being hard to differentiate between symptoms of ovarian cancer and other problems resulting in later diagnosis and worse outcomes. It is crucial that we discuss these challenges and the emotional needs of patients during such a difficult time in their lives.
Hannah Vaughan-Jones (Journalist and International News Broadcaster at CNN International) has convened leaders in the ovarian cancer space; Clara MacKay (CEO, World Ovarian Cancer Coalition), Tracie Miles, (Specialist Gynaecology Cancer Nurse), Irmina Wojtaszak (ovarian cancer patient and nurse), and Dave Fredrickson (AstraZeneca’s Executive Vice President, Oncology Business).
In this fourth section of the panel, our panel of experts covered the importance of biomarkers and molecular testing in ovarian cancer.
New Normal, Same Cancer is a partnership between AstraZeneca and over 100 global patient coalitions around the world with one clear message - Don’t wait. Contact your doctor. Get checked. See more here: www.astrazeneca.com/our-thera...
------------------------------------------------------------
Global site: www.astrazeneca.com/
Careers site: careers.astrazeneca.com/
Follow us:
Twitter: / astrazeneca
LinkedIn: / astrazeneca
Instagram: / astrazeneca
Facebook: / astrazeneca
8 ноя 2021
